Top Stories
AUTHOR

Yash Agarwal

Yash Agarwal is a financial journalist at Business Upturn, covering corporate announcements, market developments, and regulatory filings. A recent commerce graduate, he brings a sharp eye for numbers and a keen interest in India's capital markets and listed companies. Yash is reachable at [email protected]

Emcure receives US FDA Form 483 with 7 observations following inspection

Emcure Pharmaceuticals' Sanand facility in Ahmedabad received a Form 483 from the US FDA with seven procedural observations after a…

May 16, 2026
blank
1 2 3 76